TFF Pharmaceuticals, Inc. (TFFP) Financials

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0
Day's range
$0
$10M$10M$0$0-$10M-$10M-$20M-$20M-$30M-$30M-$40M-$40MEarning20172017201820182019201920202020202120212022202220232023-2893.5%-2893.5%-2894%-2894%-2894.5%-2894.5%-2895%-2895%-2895.5%-2895.5%-2896%-2896%Profit Margin
Profit Margin
Revenue
Earnings

TFFP Income statement / Annual

Last year (2023), TFF Pharmaceuticals, Inc.'s total revenue was $733.87 K, and the percentage change from the previous year is not available. In 2023, TFF Pharmaceuticals, Inc.'s net income was -$21.24 M. See TFF Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $733.87 K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $502.48 K $388.22 K $111.45 K $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $231.39 K -$388.22 K -$111.45 K $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit Ratio 0.32 0 0 0 0 0 0 0
Research and Development Expenses $11.56 M $18.50 M $21.30 M $10.68 M $8.82 M $848.81 K $0.00 $229.26 K
General & Administrative Expenses $10.57 M $13.80 M $10.57 M $8.01 M $3.17 M $0.00 $178.61 K $0.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $10.57 M $13.80 M $10.57 M $8.01 M $3.17 M $3.05 M $178.61 K $141.11 K
Other Expenses $0.00 -$495.81 K -$88.16 K $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $22.13 M $31.80 M $31.79 M $18.69 M $11.99 M $3.90 M $178.61 K $370.37 K
Cost And Expenses $22.63 M $31.80 M $31.79 M $18.69 M $11.99 M $3.90 M $178.61 K $370.37 K
Interest Income $0.00 $26.73 K $51.23 K $126.42 K $117.33 K $55.96 K $0.00 $0.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $502.48 K $388.22 K $111.45 K $206.30 K $171.86 K $0.00 $52.52 K $0.00
EBITDA -$20.74 M -$31.41 M -$30.93 M -$18.69 M -$11.99 M -$3.90 M -$178.61 K -$370.37 K
EBITDA Ratio -28.26 0 0 0 0 0 0 0
Operating Income Ratio -29.83 0 0 0 0 0 0 0
Total Other Income/Expenses Net $651.43 K $26.73 K $747.95 K $126.42 K $117.33 K $55.96 K $0.00 $0.00
Income Before Tax -$21.24 M -$31.77 M -$31.04 M -$18.57 M -$11.87 M -$3.84 M -$178.61 K -$370.37 K
Income Before Tax Ratio -28.95 0 0 0 0 0 0 0
Income Tax Expense $0.00 -$26.73 -$51.23 K -$126.42 K -$117.33 K $0.00 -$52.52 K $0.00
Net Income -$21.24 M -$31.77 M -$30.99 M -$18.44 M -$11.75 M -$3.84 M -$178.61 K -$370.37 K
Net Income Ratio -28.95 0 0 0 0 0 0 0
EPS -11.85 -26.49 -31.21 -22.57 -42.55 -5.21 -0.01 -0.5
EPS Diluted -11.85 -26.49 -31.21 -22.57 -42.55 -5.21 -0.01 -0.5
Weighted Average Shares Out $1.79 M $1.20 M $992.84 K $817.01 K $276.20 K $738.04 K $17.83 M $738.04 K
Weighted Average Shares Out Diluted $1.79 M $1.20 M $992.84 K $817.01 K $276.20 K $738.04 K $17.83 M $738.04 K
Link